These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 24721941

  • 1. Urological tumors in renal transplantation.
    Tillou X, Doerfler A.
    Minerva Urol Nefrol; 2014 Mar; 66(1):57-67. PubMed ID: 24721941
    [Abstract] [Full Text] [Related]

  • 2. [De novo urologic tumors in kidney transplant patients].
    Rodríguez Faba O, Breda A, Gausa L, Palou J, Villavicencio H.
    Actas Urol Esp; 2015 Mar; 39(2):122-7. PubMed ID: 24996779
    [Abstract] [Full Text] [Related]

  • 3. Development of urologic de novo malignancies after renal transplantation.
    Hevia V, Gómez V, Díez Nicolás V, Alvarez S, Gómez Del Cañizo C, Galeano C, Gomis A, García-Sagredo JM, Marcen R, Burgos FJ.
    Transplant Proc; 2014 Mar; 46(1):170-5. PubMed ID: 24507046
    [Abstract] [Full Text] [Related]

  • 4. [Urologic malignancies in renal transplant candidates and recipients].
    Kleinclauss F, Thuret R, Murez T, Timsit MO.
    Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux.
    Elkentaoui H, Robert G, Pasticier G, Bernhard JC, Couzi L, Merville P, Ravaud A, Ballanger P, Ferrière JM, Wallerand H.
    Urology; 2010 Jan; 75(1):126-32. PubMed ID: 19864001
    [Abstract] [Full Text] [Related]

  • 6. Development of urological cancers in renal transplant recipients: 30-year experience at the Frankfurt Transplant Center.
    Tsaur I, Karalis A, Probst M, Blaheta RA, Scheuermann EH, Gossmann J, Kachel HG, Hauser IA, Jonas D, Obermüller N.
    Cancer Sci; 2010 Nov; 101(11):2430-5. PubMed ID: 20707803
    [Abstract] [Full Text] [Related]

  • 7. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
    Zhou M, Zhu Y, Wang L, Wang Y, Fu S, Min Z.
    Clin Transpl; 2006 Nov; ():395-8. PubMed ID: 18365395
    [Abstract] [Full Text] [Related]

  • 8. The high rate of de novo graft carcinomas in renal transplant recipients.
    Viart L, Surga N, Collon S, Jaureguy M, Elalouf V, Tillou X.
    Am J Nephrol; 2013 Nov; 37(2):91-6. PubMed ID: 23363786
    [Abstract] [Full Text] [Related]

  • 9. [Urological follow-up and development of cancer after renal transplantation].
    Giessing M.
    Urologe A; 2015 Oct; 54(10):1393-401. PubMed ID: 26459582
    [Abstract] [Full Text] [Related]

  • 10. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
    di Capua Sacoto C, Luján Marco S, Bahilo Mateu P, Budía Alba A, Pontones Moreno JL, Jiménez Cruz JF.
    Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
    [Abstract] [Full Text] [Related]

  • 11. The management of transitional cell carcinoma (TCC) in a European regional renal transplant population.
    Rogers A, Ng JK, Glendinning J, Rix D.
    BJU Int; 2012 Jul; 110(2 Pt 2):E34-40. PubMed ID: 22243691
    [Abstract] [Full Text] [Related]

  • 12. De Novo Urologic Malignancies in Renal Transplant Recipients.
    Antunes H, Tavares-da-Silva E, Oliveira R, Carvalho J, Parada B, Bastos C, Figueiredo A.
    Transplant Proc; 2018 Jun; 50(5):1348-1354. PubMed ID: 29753463
    [Abstract] [Full Text] [Related]

  • 13. Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments.
    Sanderson KM, Rouprêt M.
    BJU Int; 2007 Jul; 100(1):11-6. PubMed ID: 17428248
    [Abstract] [Full Text] [Related]

  • 14. Management of Urological Malignancy in Heart and Lung Transplant Recipients: An Irish National Cohort Study.
    Keenan RA, Haroon U, Ryan P, Harrington B, Jones A, Aboelmagd M, Connolly S, O'Mally KJ, Galvin D, Hegarty N.
    Exp Clin Transplant; 2021 Oct; 19(10):1069-1075. PubMed ID: 34641776
    [Abstract] [Full Text] [Related]

  • 15. History of urological malignancies before kidney transplantation, oncological outcome on the long term.
    Boissier R, Hidalgo R, Rodríguez Faba O, Territo A, Subiela JD, Huguet J, Sánchez-Puy A, Gallioli A, Vanacore D, Mercade A, Martinez C, Palou J, Guirado L, Breda A.
    Actas Urol Esp (Engl Ed); 2021 Dec; 45(10):623-634. PubMed ID: 34764048
    [Abstract] [Full Text] [Related]

  • 16. The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review.
    Boissier R, Hevia V, Bruins HM, Budde K, Figueiredo A, Lledó-García E, Olsburgh J, Regele H, Taylor CF, Zakri RH, Yuan CY, Breda A.
    Eur Urol; 2018 Jan; 73(1):94-108. PubMed ID: 28803033
    [Abstract] [Full Text] [Related]

  • 17. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD, Sosa RE, Vaughan ED, Scherr DS.
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [Abstract] [Full Text] [Related]

  • 18. Urologic de novo malignancies after kidney transplantation: a single center experience.
    Karczewski M, Czapiewski W, Karczewski J.
    Transplant Proc; 2012 Jun; 44(5):1293-7. PubMed ID: 22664003
    [Abstract] [Full Text] [Related]

  • 19. [Transitional carcinomas of the urinary tract: synchronous and metachronous lesions].
    Arrizabalaga M, Navarro J, Mora M, Castro M, Extramiana J, Mañas A, Diez J, Paniagua P.
    Actas Urol Esp; 1994 Sep; 18(8):782-96. PubMed ID: 7998507
    [Abstract] [Full Text] [Related]

  • 20. Transitional cell carcinoma in renal transplant recipients: a single center experience.
    Li XB, Xing NZ, Wang Y, Hu XP, Yin H, Zhang XD.
    Int J Urol; 2008 Jan; 15(1):53-7. PubMed ID: 18184173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.